Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

32.72
+0.28570.88%
Post-market: 32.720.00000.00%16:10 EDT
Volume:2K
Turnover:74.53K
Market Cap:41.71M
PE:- -
High:32.81
Open:32.81
Low:32.72
Close:32.43
52wk High:35.61
52wk Low:27.50
Shares:1.28M
Float Shares:1.28M
Volume Ratio:0.61
T/O Rate:0.18%
Dividend:0.08
Dividend Rate:0.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Dow Jones
·
2 hours ago

Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug

TIPRANKS
·
4 hours ago

Lilly Expands Oncology Footprint with FDA Win for Pancreatic Cancer Drug

Dow Jones
·
Yesterday

Eli Lilly treatment of pancreatic cancer granted orphan designation

TIPRANKS
·
Yesterday

TRex Bio Files for Nasdaq IPO

MT Newswires Live
·
Yesterday

Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins

THOMSON REUTERS
·
Yesterday

Eli Lilly Presents New Ebglyss Data from Phase 3 ADorable-1 Pediatric Atopic Dermatitis Study at Fall Clinical 2026

Reuters
·
Yesterday

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Reuters
·
Yesterday

Nurix Extends Gilead Collaboration for Oncology Program

Reuters
·
Yesterday

Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026

THOMSON REUTERS
·
Yesterday

Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties

THOMSON REUTERS
·
Yesterday

Nurix - to Receive $10 Mln Research Term Extension Fee

THOMSON REUTERS
·
Yesterday

Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs

THOMSON REUTERS
·
Yesterday

Coursera, PSEG, Nauticus, Legend, Arlo Insider Shock

TIPRANKS
·
Oct 03

Eli Lilly & Co (LLY) Gets a Buy from RBC Capital

TIPRANKS
·
Oct 03

Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares

Reuters
·
Oct 03

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Oct 03

Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million

Dow Jones
·
Oct 03

Eli Lilly announces FDA approves additional indication for Jaypirca

TIPRANKS
·
Oct 03

Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca

Reuters
·
Oct 03